Tesla and Netflix among market cap stock movers on Wednesday

Published 03/12/2025, 16:34
© Reuters.

Wednesday’s market has seen swings in various stocks based on news and other factors. Today, stocks like Tesla (TSLA) are rallying, while stocks like Netflix (NFLX) are falling. Below are highlights of some of the biggest stock movers, from mega-caps to small caps.

Mega-Cap Movers (Market Cap:$200 billion USD or higher)

  • Netflix (NFLX); Comcast (CMCSA) bid to merge NBCUniversal unit with Warner Bros - Bloomberg; -5.97%
  • Microsoft (MSFT); Microsoft Lowers AI Software Sales Quotas as Customers Resist Newer Products; -2.37%
  • Micron Tech (MU); -1.95%
  • Alibaba-exch (BABA); -2.04%
  • Tesla Motors (TSLA); After AI Push, Trump Administration Is Now Looking To Robots; +2.76%

Large-Cap Stock Movers (Market Cap:$10-$200 billion USD)

Mid-Cap Stock Movers (Market Cap:$2-$10 billion USD)

  • Gitlab (GTLB); GitLab appoints Jessica Ross as new CFO effective January 2026; -15.03%
  • Adaptive Biotechnologies Corp (ADPT); -9.5%
  • Diginex Inc (DGNX); -10.0%
  • Fermi America LLC (FRMI); -6.66%
  • ELF Beauty Inc (ELF); +8.05%
  • dMY Technology Group II (GENI); +8.75%
  • Regencell Bioscience Holdings (RGC); +8.1%
  • American Eagle Outfitters (AEO); American Eagle stock soars 11% on strong Q3 results, raised guidance; +13.97%
  • SeaCube Container Leasing Ltd (BOX); Box Inc stocks plunge over 10% on bottom-line miss in Q3; +7.29%
  • MTech Acquisition A (ABTC); +6.16%

Small-Cap Stock Movers (Market Cap:$300 million - $2 billion USD)

  • Ambitions Enterprise Management Co (AHMA); +43.51%
  • MapLight Therapeutics Inc (MPLT); +26.38%
  • Anavex Life Sciences (AVXL); +23.21%
  • InterPrivate Acquisition (AEVA); European automaker selects Aeva as exclusive lidar supplier; +17.4%
  • Pharvaris BV (PHVS); Pharvaris reports positive phase 3 results for HAE attack treatment; +17.0%
  • Carbylan Therapeutics Inc (KALV); +17.38%
  • POET Tech NAQ (POET); +13.93%
  • TryHard Holdings (THH); -19.71%
  • Acadia Healthcare (ACHC); Acadia Healthcare stock rating downgraded by BofA on higher insurance costs; -14.68%
  • Adc Therapeutics SA (ADCT); ZYNLONTA-glofitamab combo shows 90% response rate in lymphoma trial; -29.35%

For real-time, market-moving news, join Investing Pro.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.